PL3468964T3 - Modulatory soce, ich kompozycje i zastosowania - Google Patents

Modulatory soce, ich kompozycje i zastosowania

Info

Publication number
PL3468964T3
PL3468964T3 PL17732232T PL17732232T PL3468964T3 PL 3468964 T3 PL3468964 T3 PL 3468964T3 PL 17732232 T PL17732232 T PL 17732232T PL 17732232 T PL17732232 T PL 17732232T PL 3468964 T3 PL3468964 T3 PL 3468964T3
Authority
PL
Poland
Prior art keywords
soce
modulators
compositions
Prior art date
Application number
PL17732232T
Other languages
English (en)
Inventor
Tracey Pirali
Armando A. GENAZZANI
Beatrice RIVA
Original Assignee
Università Degli Studi Del Piemonte Orientale "Amedeo Avogadro"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Università Degli Studi Del Piemonte Orientale "Amedeo Avogadro" filed Critical Università Degli Studi Del Piemonte Orientale "Amedeo Avogadro"
Publication of PL3468964T3 publication Critical patent/PL3468964T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inductance-Capacitance Distribution Constants And Capacitance-Resistance Oscillators (AREA)
PL17732232T 2016-06-08 2017-06-07 Modulatory soce, ich kompozycje i zastosowania PL3468964T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITUA2016A004199A ITUA20164199A1 (it) 2016-06-08 2016-06-08 Modulatori di soce compisizioni e relativi usi
PCT/IB2017/053355 WO2017212414A1 (en) 2016-06-08 2017-06-07 Modulators of soce, compositions, and uses thereof
EP17732232.8A EP3468964B1 (en) 2016-06-08 2017-06-07 Modulators of soce, compositions, and uses thereof

Publications (1)

Publication Number Publication Date
PL3468964T3 true PL3468964T3 (pl) 2021-07-12

Family

ID=57113604

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17732232T PL3468964T3 (pl) 2016-06-08 2017-06-07 Modulatory soce, ich kompozycje i zastosowania

Country Status (7)

Country Link
US (1) US10519138B2 (pl)
EP (1) EP3468964B1 (pl)
DK (1) DK3468964T3 (pl)
ES (1) ES2861317T3 (pl)
IT (1) ITUA20164199A1 (pl)
PL (1) PL3468964T3 (pl)
WO (1) WO2017212414A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113557020A (zh) 2018-09-14 2021-10-26 瑞真药业公司 包含crac抑制剂和皮质类固醇的组合物及其使用方法
CA3115230A1 (en) * 2018-10-04 2020-04-09 The Trustees Of Indiana University Methods to treat renal disorders using calcium channel inhibitors
CN111153817B (zh) * 2020-01-20 2021-02-02 四川大学 苯氧基-n-苯基苯胺衍生物及其应用
IT202000003692A1 (it) * 2020-02-21 2021-08-21 Univ Degli Studi Del Piemonte Orientale Amedeo Avogadro Composti bifenilici come modulatori di soce, loro composizioni e usi
CN111494370B (zh) * 2020-03-30 2021-07-06 中南大学湘雅二医院 Pyr3在制备保护肝损伤的药物中的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010044445A1 (en) 1999-04-08 2001-11-22 Bamaung Nwe Y. Azole inhibitors of cytokine production
DE10149370A1 (de) * 2001-10-06 2003-04-10 Merck Patent Gmbh Pyrazolderivate
CA2606239A1 (en) 2005-04-22 2006-11-02 Astellas Pharma Inc. Preventive or remedy for bowel disease
US8039502B2 (en) * 2007-07-24 2011-10-18 The Ohio State University Research Foundation Anti-infective agents against intracellular pathogens
US8389567B2 (en) 2007-12-12 2013-03-05 Calcimedica, Inc. Compounds that modulate intracellular calcium
US20110230536A1 (en) 2008-10-24 2011-09-22 Calcimedica, Inc. Phenylpyrazole inhibitors of store operated calcium release
EP2421834A1 (en) * 2009-04-24 2012-02-29 Glaxo Group Limited Pyrazole and triazole carboxamides as crac channel inhibitors
US20100273744A1 (en) 2009-04-24 2010-10-28 Paul Martin Gore Compounds
US8993612B2 (en) 2009-10-08 2015-03-31 Rhizen Pharmaceuticals Sa Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer
US8377970B2 (en) * 2009-10-08 2013-02-19 Rhizen Pharmaceuticals Sa Modulators of calcium release-activated calcium channel
WO2011139489A2 (en) 2010-04-27 2011-11-10 Calcimedica Inc. Compounds that modulate intracellular calcium
JP2013525448A (ja) 2010-04-27 2013-06-20 カルシメディカ，インク． 細胞内カルシウムを調節する化合物
US20130090334A1 (en) 2011-10-05 2013-04-11 Hoffmann-La Roche Inc Azabenzoxazine derivatives as crac modulators
WO2013050270A1 (en) 2011-10-05 2013-04-11 F. Hoffmann-La Roche Ag Benzoxazine derivatives as crac modulators
US20130158040A1 (en) 2011-12-20 2013-06-20 Hoffmann-La Roche Inc. Diazaindole inhibitors of crac
US20130158066A1 (en) 2011-12-20 2013-06-20 Hoffmann-La Roche Inc. 4-azaindole inhibitors of crac
US20130158049A1 (en) 2011-12-20 2013-06-20 Hoffmann-La Roche Inc. 7-azaindole inhibitors of crac
ES2694001T3 (es) * 2013-03-15 2018-12-17 Bristol-Myers Squibb Company Moduladores de LXR

Also Published As

Publication number Publication date
US20190300509A1 (en) 2019-10-03
EP3468964A1 (en) 2019-04-17
US10519138B2 (en) 2019-12-31
DK3468964T3 (da) 2021-03-15
ITUA20164199A1 (it) 2017-12-08
ES2861317T3 (es) 2021-10-06
WO2017212414A1 (en) 2017-12-14
EP3468964B1 (en) 2020-12-30

Similar Documents

Publication Publication Date Title
HUE065174T2 (hu) HLA-alapú módszerek és készítmények, valamint azok felhasználása
IL259246A (en) Preparations containing pharmaceutical substances and methods of using them
IL264446A (en) Compounds and compositions and their use
ZA201903928B (en) Compositions comprising methylphenidate-prodrugs, processes of making and using the same
GB201705091D0 (en) Compositions and methods and uses relating thereto
GB201502002D0 (en) Uses and compositions
PL3468964T3 (pl) Modulatory soce, ich kompozycje i zastosowania
GB201608762D0 (en) Compositions and uses thereof
SG10202100751YA (en) Compounds and compositions and uses thereof
GB202004930D0 (en) Composition and uses thereof
GB201501991D0 (en) Uses and compositions
GB201502026D0 (en) Uses and compositions
PT3503885T (pt) Composição farmacêutica e métodos de utilização
GB201712592D0 (en) Novel compositions and uses thereof
GB201614897D0 (en) Compositions and uses thereof
GB201511886D0 (en) Uses and compositions
GB2607546B (en) Functional composition and uses thereof
IL259900A (en) Aminoazole derivatives, compositions containing same and uses thereof
GB201812952D0 (en) Compositions and uses thereof
GB201602409D0 (en) Compositions and uses thereof
GB201522814D0 (en) Compositions and uses thereof
ZA201903341B (en) Pharmaceutical compositions and uses thereof
IL248576A0 (en) Anti-lice preparation and its uses
GB201713920D0 (en) Pharmaceutical compositions and uses thereof
AU2016905199A0 (en) Composition And Uses Thereof